Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/R-HDAC> ?p ?o }
Showing triples 1 to 33 of
33
with 100 triples per page.
- R-HDAC abstract "R-HDAC, or R-HD-AraC ((R)ituximab plus (H)igh (D)ose (A)ra-(C)) is a chemotherapy regimen that is used, alternating with R-Maxi-CHOP, as part of so-called \"Nordic protocol\" of treating mantle cell lymphoma. It consists of monoclonal antibody rituximab and high-dose antimetabolite cytarabine.High dose Ara-C (HDAC) without rituximab also has several other uses in oncohematology. For example, HDAC, alone or alternating with HD-MTX, is often used for primary CNS lymphoma and for treating CNS involvement in any lymphomas, and also for so-called \"CNS prophylaxis\" (prophylactic use in those forms of lymphoma which show no signs of CNS involvement at diagnosis but have high chance of CNS relapse or recurrence). HDAC is also used as a consolidation regimen in acute myeloid leukemia after initial 7+3 induction. HDAC also can be used as the primary induction therapy in AML, with higher than in 7+3 success (remission) rate, but it is more toxic and causes more treatment-related complications and treatment-related mortality than 7+3 when used as primary induction therapy.".
- R-HDAC wikiPageID "43797750".
- R-HDAC wikiPageLength "1842".
- R-HDAC wikiPageOutDegree "18".
- R-HDAC wikiPageRevisionID "626052386".
- R-HDAC wikiPageWikiLink Acute_myeloid_leukemia.
- R-HDAC wikiPageWikiLink Antibody.
- R-HDAC wikiPageWikiLink Antimetabolite.
- R-HDAC wikiPageWikiLink CHOP.
- R-HDAC wikiPageWikiLink Category:Chemotherapy_regimens_used_in_acute_myeloid_leukemia.
- R-HDAC wikiPageWikiLink Category:Chemotherapy_regimens_used_in_lymphoma.
- R-HDAC wikiPageWikiLink Chemotherapy_regimen.
- R-HDAC wikiPageWikiLink Cytarabine.
- R-HDAC wikiPageWikiLink Lymphoma.
- R-HDAC wikiPageWikiLink Mantle_cell_lymphoma.
- R-HDAC wikiPageWikiLink Monoclonal_antibody.
- R-HDAC wikiPageWikiLink Primary_central_nervous_system_lymphoma.
- R-HDAC wikiPageWikiLink Rituximab.
- R-HDAC wikiPageWikiLinkText "HDAC or HD-AraC".
- R-HDAC wikiPageWikiLinkText "R-HDAC".
- R-HDAC wikiPageWikiLinkText "high-dose cytarabine".
- R-HDAC wikiPageUsesTemplate Template:Reflist.
- R-HDAC subject Category:Chemotherapy_regimens_used_in_acute_myeloid_leukemia.
- R-HDAC subject Category:Chemotherapy_regimens_used_in_lymphoma.
- R-HDAC hypernym Regimen.
- R-HDAC comment "R-HDAC, or R-HD-AraC ((R)ituximab plus (H)igh (D)ose (A)ra-(C)) is a chemotherapy regimen that is used, alternating with R-Maxi-CHOP, as part of so-called \"Nordic protocol\" of treating mantle cell lymphoma. It consists of monoclonal antibody rituximab and high-dose antimetabolite cytarabine.High dose Ara-C (HDAC) without rituximab also has several other uses in oncohematology.".
- R-HDAC label "R-HDAC".
- R-HDAC sameAs Q18015294.
- R-HDAC sameAs m.011v8fr1.
- R-HDAC sameAs R-HDAC.
- R-HDAC sameAs Q18015294.
- R-HDAC wasDerivedFrom R-HDAC?oldid=626052386.
- R-HDAC isPrimaryTopicOf R-HDAC.